Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastrointestinal tract barrier function
- Molecular classification
- Other (Physiological barrier function, not a discrete molecule or molecular class)
01
Overview
The gastrointestinal tract barrier function refers to the physiological role of the gut wall in separating the internal milieu from the external environment, primarily via the mucus layer, intestinal epithelial cells joined by tight and adherens junctions, and the gut vascular barrier[1][2][4]. This barrier selectively permits the absorption of nutrients and water while blocking the passage of pathogens, toxins, and antigens. Its integrity is maintained by complex interactions between epithelial cells, immune cells in the lamina propria, commensal microbiota, and secreted proteins like mucins and antimicrobial peptides. Barrier dysfunction is implicated in a wide spectrum of gastrointestinal and systemic diseases, and various therapeutic approaches aim to restore its integrity by targeting these underlying molecular and cellular components[1][2][4].
- Other names
- Intestinal barrier functionGut barrierIntestinal epithelial barrierGut epithelial barrier
02
Mechanism of action
Enhancement or restoration of tight junctions; Regulation of mucin production; Modulation of inflammatory cytokines; Alteration of gut microbiota composition
03
Biological functions
Barrier to pathogen entryRegulation of nutrient absorptionHost–microbiota homeostasisImmune defense
04
Disease associations
Inflammation (e.g., inflammatory bowel disease)InfectionCancer (e.g., colon carcinoma)Metabolic disorders (e.g., obesity, diabetes)Extra-intestinal autoimmune diseases
05
Safety considerations
Non-specific modulation may alter absorption of nutrients or drugsImmunosuppression risk if barrier restoration relies on anti-inflammatory therapyDysbiosis risk with microbiota-targeting interventions
06
Interacting drugs
No drugs interact directly with "gastrointestinal tract barrier function" as a molecule, but drugs can modulate barrier function indirectly (e.g., mucoprotectants, anti-inflammatory agents, probiotics)
07
Biomarkers
Increased intestinal permeability (e.g., measured by lactulose/mannitol test)Reduced expression of tight junction proteins (e.g., occludin, claudins, ZO-1)Biomarkers of epithelial damage (e.g., fecal calprotectin, MUC2 levels)
Beyond the preview
Go deeper on Gastrointestinal tract barrier function.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gastrointestinal tract barrier function.